GlycoNex (4168) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.017x

Based on the latest financial reports, GlycoNex (4168) has a cash flow conversion efficiency ratio of -0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-17.29 Million ≈ $-544.86K USD) by net assets (NT$1.01 Billion ≈ $31.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4168 equity financing ratio to measure how much of total assets are equity-financed.

GlycoNex - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how GlycoNex's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GlycoNex cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

GlycoNex Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GlycoNex ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Energous Corporation NASDAQ:WATT	-0.130x
MAIA Biotechnology Inc. NYSE MKT:MAIA	-0.191x
Asetek A/S F:A31	0.018x
District Metals Corp V:DMX	-0.027x
Axon Partners Group S.A. MC:APG	0.065x
Gascogne SA PA:ALBI	0.011x
Vocento MC:VOC	-0.045x
Investec plc LSE:INVR	0.009x

Annual Cash Flow Conversion Efficiency for GlycoNex (2017–2024)

The table below shows the annual cash flow conversion efficiency of GlycoNex from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see GlycoNex stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.05 Billion ≈ $32.97 Million	NT$-221.97 Million ≈ $-6.99 Million	-0.212x	-47.20%
2023-12-31	NT$1.28 Billion ≈ $40.21 Million	NT$-183.92 Million ≈ $-5.79 Million	-0.144x	-24.32%
2022-12-31	NT$1.45 Billion ≈ $45.54 Million	NT$-167.55 Million ≈ $-5.28 Million	-0.116x	-11.81%
2021-12-31	NT$1.36 Billion ≈ $42.81 Million	NT$-140.86 Million ≈ $-4.44 Million	-0.104x	-9.61%
2020-12-31	NT$1.54 Billion ≈ $48.51 Million	NT$-145.59 Million ≈ $-4.59 Million	-0.095x	+31.50%
2019-12-31	NT$1.30 Billion ≈ $40.98 Million	NT$-179.58 Million ≈ $-5.66 Million	-0.138x	-17.31%
2018-12-31	NT$1.53 Billion ≈ $48.28 Million	NT$-180.34 Million ≈ $-5.68 Million	-0.118x	-452.73%
2017-12-31	NT$1.84 Billion ≈ $58.01 Million	NT$61.43 Million ≈ $1.94 Million	0.033x	--

About GlycoNex

TWO:4168 Taiwan Biotechnology

Market Cap

$77.61 Million

NT$2.46 Billion TWD

Market Cap Rank

#20102 Global

#1170 in Taiwan

Share Price

NT$22.25

Change (1 day)

+0.91%

52-Week Range

NT$20.80 - NT$29.40

All Time High

NT$67.99